Staff editor

Metabolomics in alcohol dependence: uncovering biomarkers and gut-brain interactions through new technologies

Nathalie Maria Delzenne from Université Catholique de Louvain (Belgium) explains how gut microbiota and systemic inflammation impact cravings and depressive symptoms in affected individuals. 

Microbio’s MS-20 shows breakthrough potential in enhancing Keytruda for advanced lung cancer

The study revealed that MS-20 dramatically improved treatment outcomes, tripling the objective response rate (ORR) to 75% when combined with Keytruda.

Integrating microbiome data into food safety: EFSA’s approach to risk assessment in the agri-food chain

Konstantinos Paraskevopoulos (European Food Security Autority, EFSA) underscores the importance of microbiome data in assessing the safety of food and feed products across the agri-food chain.

The double-edged sword of dietary fiber: tailoring fiber intake for gut health in autoimmune conditions

Heather Armstrong, from University of Manitoba and University of Alberta (Canada), explores the intricate role of dietary fibers in maintaining gut health, focusing on the microbiome’s ability to process these…

Personalized nutrition in a changing world: addressing global health challenges with lifestyle medicine and omics

Hellas Cena, from University of Pavia (Italy), emphasizes the growing importance of nutrition in addressing current global health challenges.

MaaT Pharma reports positive Phase 1b results for MaaT033 in ALS, setting the stage for future advances

A significant milestone for both microbiome research and neurodegenerative diseases.

Microbial signatures for food traceability: ensuring quality and safety from fermented wines to novel insect-based foods

The interview with Antonia Bruno, from Bicocca University of Milan (Italy), highlights research focused on using microbial signatures to enhance food traceability, ensuring both safety and quality. 

Freya Biosciences secures $10.4 million investment to tackle women’s health challenges

A Bill & Melinda Gates Foundation strategic investment to tackle bacterial vaginosis and improve maternal and neonatal health outcomes worldwide.

From Biofarma Group a probiotic therapy as an adjuvant to cancer immunotherapy

Biofarma Group has launched an innovative project in collaboration with the Department of Surgery, Endocrinology and Gastroenterology of the University of Naples ‘Federico II’, the Centro Sperimentale del Latte (CSL)…

QIAGEN and McGill University partner to drive innovation in microbiome research

Three-year collaboration to pioneer new insights in microbial sciences and health applications.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.